Real-world effectiveness and safety of ritlecitinib in adolescents with severe alopecia areata
A 36-week single-center study.
Starace M, Cedirian S, Pampaloni F, Rapparini L, Quadrelli F, Bruni F, Martelli G, Piraccini BM
Journal of the American Academy of DermatologyIn the feed 7 Jul 2026, published online 7 Jul 2026, issue 2026 Jul 07, added to PubMed 7 Jul 2026
Topics: HairChildrenJAK inhibitors & other targeted pills
Abstract
PubMed has no abstract for this paper, as is usual for research letters, correspondence and editorials. The publisher’s page has the full paper.
PMID 42413780 · DOI 10.1016/j.jaad.2026.07.009